Cristina Bergamaschi
0000-0003-1030-2662
2 papers found
Refreshing results…
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
Heterodimeric IL-15 in Cancer Immunotherapy
Missing publications? Search for publications with a matching author name.